Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Patrick Markt"'
Autor:
Rebecca Herzog, Freya Klepsch, Klaus Kratochwill, Bernd Boidol, Michael Caldera, Y. Folkvaljon, Charles-Hugues Lardeau, Jörg Menche, André C. Müller, Patrick Markt, Sara Sdelci, Gerhard Dürnberger, Vladimir V. Ivanov, Stefan Kubicek, Pär Stattin, Michael Schuster, Thomas Penz, Erika Schirghuber, Christoph Bock, Anna Ringler, Anja Wagner, Jacques Colinge, Keiryn L. Bennett, Marco P. Licciardello
Publikováno v:
Nature Chemical Biology
Nature Chemical Biology, Nature Publishing Group, 2017, 13 (7), pp.771-778. ⟨10.1038/nchembio.2382⟩
Nature Chemical Biology, 2017, 13 (7), pp.771-778. ⟨10.1038/nchembio.2382⟩
Nature Chemical Biology, Nature Publishing Group, 2017, 13 (7), pp.771-778. ⟨10.1038/nchembio.2382⟩
Nature Chemical Biology, 2017, 13 (7), pp.771-778. ⟨10.1038/nchembio.2382⟩
International audience; Approved drugs are invaluable tools to study biochemical pathways, and further characterization of these compounds may lead to repurposing of single drugs or combinations. Here we describe a collection of 308 small molecules r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a88549e693cbccd83e6eb3bddb6defea
https://hal.umontpellier.fr/hal-02278677
https://hal.umontpellier.fr/hal-02278677
Autor:
Stefano Alcaro, Francesca Esposito, Simona Distinto, Elias Maccioni, Patrick Markt, Johannes Kirchmair, M. Cristina Cardia, Marco Gaspari, Gerhard Wolber, Luca Zinzula, Enzo Tramontano
Publikováno v:
European Journal of Medicinal Chemistry. 50:216-229
We report the first application of ligand-based virtual screening (VS) methods for discovering new compounds able to inhibit both human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT)-associated functions, DNA polymerase and ribonucl
Pharmacophore-based discovery of FXR agonists. Part I: Model development and experimental validation
Autor:
Hermann Stuppner, Valery N. Bochkov, Judith M. Rollinger, Ulrike Grienke, Patrick Markt, Stefan M. Noha, Daniela Schuster, Gerhard Wolber, Markus Binder, Judit Mihaly-Bison
Publikováno v:
Bioorganic & Medicinal Chemistry
Graphical abstract
The farnesoid X receptor (FXR) is involved in glucose and lipid metabolism regulation, which makes it an attractive target for the metabolic syndrome, dyslipidemia, atherosclerosis, and type 2 diabetes. In order to find novel
The farnesoid X receptor (FXR) is involved in glucose and lipid metabolism regulation, which makes it an attractive target for the metabolic syndrome, dyslipidemia, atherosclerosis, and type 2 diabetes. In order to find novel
Autor:
Dorota Kowalik, Patrick Markt, Gabriele Möller, Alex Odermatt, Christian Laggner, Gerhard Wolber, Daniela Schuster, Fabian Ströhle, Jerzy Adamski, Thomas Wilckens, Johannes Kirchmair, Christel Aebischer-Gumy, Thierry Langer
Publikováno v:
The Journal of steroid biochemistry and molecular biology
17β-Hydroxysteroid dehydrogenase type 3 and 5 (17β-HSD3 and 17β-HSD5) catalyze testosterone biosynthesis and thereby constitute therapeutic targets for androgen-related diseases or endocrine-disrupting chemicals. As a fast and efficient tool to id
Autor:
Hermann Stuppner, Gerhard Wolber, Judith M. Rollinger, Daniela Schuster, Julia Bauer, Oliver Werz, Stefan M. Noha, Patrick Markt, Katja Wiechmann, Birgit Waltenberger
Publikováno v:
Journal of Medicinal Chemistry. 54:3163-3174
Microsomal prostaglandin E2 synthase-1 (mPGES-1) catalyzes prostaglandin E2 formation and is considered as a potential anti-inflammatory pharmacological target. To identify novel chemical scaffolds active on this enzyme, two pharmacophore models for
Autor:
Tatyana Kharlamova, Angela Corona, Francesca Esposito, Giovanni Floris, Simona Distinto, Luca Zinzula, Yung-Chi Cheng, Ginger E. Dutschman, Enzo Tramontano, Patrick Markt
Publikováno v:
FEBS Journal. 278:1444-1457
HIV-1 reverse transcriptase (RT) has two associated activities, DNA polymerase and RNase H, both essential for viral replication and validated drug targets. Although all RT inhibitors approved for therapy target DNA polymerase activity, the search fo
Autor:
Verena M. Dirsch, Atanas G. Atanasov, Judith M. Rollinger, Hermann Stuppner, Stefan M. Noha, Gerhard Wolber, Patrick Markt, Elke H. Heiss, Daniela Schuster, Nanang Fakhrudin, Olivia Schrammel
Publikováno v:
Bioorganic & Medicinal Chemistry Letters
Graphical abstract
Various inflammatory stimuli that activate the nuclear factor kappa B (NF-κB) signaling pathway converge on a serine/threonine kinase that displays a key role in the activation of NF-κB: the I kappa B kinase β (IKK-β). The
Various inflammatory stimuli that activate the nuclear factor kappa B (NF-κB) signaling pathway converge on a serine/threonine kinase that displays a key role in the activation of NF-κB: the I kappa B kinase β (IKK-β). The
Autor:
Ulrich Kintscher, Patrick Markt, Gerhard Wolber, Thomas Unger, Matthias Goebel, Ronald Gust, Bart Staels
Publikováno v:
Bioorganic & Medicinal Chemistry. 18:5885-5895
In this and previous studies we investigated the importance of partial structures of Telmisartan on PPARgamma activation. The biphenyl-4-ylmethyl moiety at N1 and residues at C2 of the central benzimidazole were identified to be essential for recepto
Autor:
Daniela Schuster, Patrick Markt, Simona Distinto, Johannes Kirchmair, Judith M. Rollinger, Hermann Stuppner, Gerhard Wolber, Birgit Waltenberger
Publikováno v:
Molecular Informatics. 29:75-86
3D pharmacophore modeling has evolved as an established and state-of-the-art method for performing in-silico predictions of biological activity. Using one single model is limited to single binding modes, while the combination of several models bears
Autor:
Elke H. Heiss, Patrick Markt, Angela Ladurner, Atanas G. Atanasov, Verena M. Dirsch, Ernst P. Ellmerer, Lisa Baumgartner, Gerhard Wolber, Hermann Stuppner, Daniela Schuster, Nanang Fakhrudin, Judith M. Rollinger
Publikováno v:
Molecular Pharmacology. 77:559-566
Peroxisome proliferator-activated receptor gamma (PPAR gamma) agonists are used for the treatment of type 2 diabetes and metabolic syndrome. However, the currently used PPAR gamma agonists display serious side effects, which has led to a great intere